| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Drug-Eluting Stents | 3 | 2019 | 562 | 1.27 | Why? |
| Self Expandable Metallic Stents | 1 | 2017 | 52 | 0.69 | Why? |
| Endarterectomy | 4 | 2019 | 60 | 0.68 | Why? |
| Metals | 1 | 2019 | 182 | 0.66 | Why? |
| Celiac Disease | 6 | 2018 | 471 | 0.66 | Why? |
| Percutaneous Coronary Intervention | 3 | 2019 | 3646 | 0.66 | Why? |
| Coronary Occlusion | 1 | 2017 | 138 | 0.61 | Why? |
| Myocardial Ischemia | 2 | 2019 | 781 | 0.57 | Why? |
| Dermatologic Agents | 1 | 2020 | 489 | 0.55 | Why? |
| Life Expectancy | 1 | 2017 | 474 | 0.48 | Why? |
| Stents | 1 | 2019 | 916 | 0.45 | Why? |
| Coronary Artery Bypass | 1 | 2017 | 629 | 0.43 | Why? |
| Plasma | 1 | 2020 | 1809 | 0.40 | Why? |
| Ultrasonography, Interventional | 1 | 2013 | 560 | 0.37 | Why? |
| Out-of-Hospital Cardiac Arrest | 4 | 2020 | 1047 | 0.36 | Why? |
| Immunization, Passive | 3 | 2020 | 10067 | 0.35 | Why? |
| Psoriasis | 1 | 2020 | 1739 | 0.32 | Why? |
| Renal Insufficiency, Chronic | 2 | 2017 | 2654 | 0.31 | Why? |
| Lung Transplantation | 1 | 2017 | 1554 | 0.31 | Why? |
| Device Removal | 2 | 2018 | 221 | 0.31 | Why? |
| Pulmonary Artery | 3 | 2019 | 803 | 0.30 | Why? |
| Biological Products | 1 | 2020 | 2331 | 0.30 | Why? |
| Immunosuppressive Agents | 2 | 2020 | 6331 | 0.29 | Why? |
| Neuroendocrine Tumors | 2 | 2018 | 241 | 0.29 | Why? |
| Computer Security | 2 | 2020 | 408 | 0.28 | Why? |
| Hypertension, Pulmonary | 3 | 2018 | 970 | 0.25 | Why? |
| Kidney Failure, Chronic | 1 | 2019 | 3222 | 0.24 | Why? |
| Renal Dialysis | 1 | 2019 | 4358 | 0.23 | Why? |
| Myocardial Infarction | 1 | 2017 | 3361 | 0.22 | Why? |
| Follow-Up Studies | 13 | 2020 | 17020 | 0.21 | Why? |
| Equipment Failure | 2 | 2018 | 197 | 0.20 | Why? |
| Intestinal Mucosa | 2 | 2018 | 1046 | 0.20 | Why? |
| Phrenic Nerve | 1 | 2018 | 37 | 0.19 | Why? |
| Splenomegaly | 1 | 2018 | 43 | 0.19 | Why? |
| Antigens, Differentiation | 1 | 2020 | 172 | 0.19 | Why? |
| Heart Arrest, Induced | 1 | 2018 | 8 | 0.19 | Why? |
| Chromogranin A | 1 | 2018 | 15 | 0.19 | Why? |
| Endothelin-1 | 1 | 2018 | 69 | 0.19 | Why? |
| Coronary Artery Disease | 1 | 2013 | 2570 | 0.19 | Why? |
| Adenoids | 1 | 2018 | 21 | 0.18 | Why? |
| Italy | 18 | 2021 | 38444 | 0.18 | Why? |
| Pouchitis | 1 | 2018 | 20 | 0.18 | Why? |
| Receptor for Advanced Glycation End Products | 1 | 2019 | 100 | 0.18 | Why? |
| Treatment Outcome | 12 | 2020 | 51732 | 0.18 | Why? |
| Adenoidectomy | 1 | 2018 | 41 | 0.18 | Why? |
| Lasers | 1 | 2018 | 132 | 0.18 | Why? |
| Crohn Disease | 2 | 2017 | 959 | 0.18 | Why? |
| Data Warehousing | 1 | 2019 | 116 | 0.17 | Why? |
| Body Composition | 2 | 2018 | 414 | 0.17 | Why? |
| Middle Aged | 43 | 2021 | 270681 | 0.17 | Why? |
| Telomerase | 1 | 2017 | 45 | 0.17 | Why? |
| Intestinal Neoplasms | 1 | 2017 | 42 | 0.17 | Why? |
| Peripheral Nerve Injuries | 1 | 2018 | 114 | 0.17 | Why? |
| Male | 52 | 2021 | 367725 | 0.17 | Why? |
| Quality of Life | 2 | 2017 | 9820 | 0.17 | Why? |
| Bundle-Branch Block | 1 | 2018 | 127 | 0.17 | Why? |
| Giant Cell Arteritis | 1 | 2019 | 137 | 0.17 | Why? |
| Alternative Splicing | 1 | 2017 | 82 | 0.17 | Why? |
| Intestine, Small | 2 | 2017 | 336 | 0.17 | Why? |
| Echocardiography, Doppler | 1 | 2019 | 269 | 0.17 | Why? |
| Isoantibodies | 1 | 2018 | 134 | 0.17 | Why? |
| Serotonin | 1 | 2018 | 137 | 0.17 | Why? |
| Splenectomy | 1 | 2017 | 85 | 0.17 | Why? |
| Aged | 38 | 2020 | 215776 | 0.16 | Why? |
| Parenteral Nutrition | 1 | 2018 | 184 | 0.16 | Why? |
| Liver Failure | 1 | 2020 | 266 | 0.16 | Why? |
| Defibrillators, Implantable | 3 | 2018 | 624 | 0.16 | Why? |
| Emergency Medical Service Communication Systems | 1 | 2017 | 48 | 0.16 | Why? |
| Arthritis | 1 | 2020 | 288 | 0.16 | Why? |
| Radiography, Interventional | 1 | 2018 | 158 | 0.16 | Why? |
| Plasmapheresis | 1 | 2020 | 437 | 0.16 | Why? |
| Radiation Exposure | 1 | 2018 | 161 | 0.16 | Why? |
| Female | 49 | 2021 | 380317 | 0.16 | Why? |
| Antirheumatic Agents | 3 | 2020 | 3023 | 0.16 | Why? |
| Prosthesis Design | 1 | 2019 | 594 | 0.16 | Why? |
| Laser Therapy | 1 | 2018 | 158 | 0.15 | Why? |
| Regenerative Medicine | 1 | 2018 | 161 | 0.15 | Why? |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2019 | 235 | 0.15 | Why? |
| Muscle Strength | 1 | 2018 | 317 | 0.15 | Why? |
| Cardiac Resynchronization Therapy | 1 | 2018 | 191 | 0.15 | Why? |
| Child Mortality | 1 | 2018 | 163 | 0.15 | Why? |
| Cicatrix | 1 | 2017 | 129 | 0.15 | Why? |
| Exercise Tolerance | 2 | 2019 | 634 | 0.15 | Why? |
| Ventricular Fibrillation | 1 | 2017 | 126 | 0.15 | Why? |
| Hypothermia, Induced | 1 | 2018 | 176 | 0.15 | Why? |
| Kidney | 3 | 2018 | 3648 | 0.15 | Why? |
| Immune Sera | 1 | 2020 | 884 | 0.15 | Why? |
| Ventricular Function, Right | 1 | 2019 | 388 | 0.15 | Why? |
| Vitamin B 12 | 1 | 2016 | 132 | 0.15 | Why? |
| Dietary Supplements | 2 | 2018 | 2251 | 0.15 | Why? |
| Diaphragm | 1 | 2018 | 232 | 0.15 | Why? |
| Network Meta-Analysis | 1 | 2017 | 426 | 0.15 | Why? |
| Graft Survival | 1 | 2018 | 587 | 0.15 | Why? |
| Promoter Regions, Genetic | 1 | 2019 | 823 | 0.15 | Why? |
| Severity of Illness Index | 5 | 2020 | 48226 | 0.14 | Why? |
| Multidetector Computed Tomography | 1 | 2018 | 307 | 0.14 | Why? |
| Cardiopulmonary Resuscitation | 2 | 2020 | 1876 | 0.14 | Why? |
| Abdomen | 1 | 2018 | 424 | 0.14 | Why? |
| Walk Test | 1 | 2017 | 461 | 0.14 | Why? |
| Forced Expiratory Volume | 1 | 2017 | 632 | 0.14 | Why? |
| Drug Administration Schedule | 2 | 2020 | 2324 | 0.14 | Why? |
| Privacy | 1 | 2020 | 636 | 0.14 | Why? |
| Spleen | 1 | 2018 | 877 | 0.13 | Why? |
| Carcinoma | 1 | 2017 | 256 | 0.13 | Why? |
| Respiratory Function Tests | 2 | 2019 | 1755 | 0.13 | Why? |
| Bone Marrow | 1 | 2017 | 492 | 0.13 | Why? |
| Gene Expression Regulation, Enzymologic | 1 | 2017 | 436 | 0.13 | Why? |
| Adrenergic beta-Antagonists | 1 | 2017 | 465 | 0.13 | Why? |
| Radiation Dosage | 1 | 2018 | 585 | 0.13 | Why? |
| Humans | 63 | 2021 | 930598 | 0.13 | Why? |
| Pericardial Effusion | 1 | 2018 | 312 | 0.13 | Why? |
| Time Factors | 8 | 2020 | 31397 | 0.13 | Why? |
| Cell- and Tissue-Based Therapy | 1 | 2018 | 422 | 0.13 | Why? |
| Colonic Neoplasms | 1 | 2017 | 295 | 0.13 | Why? |
| Aged, 80 and over | 19 | 2020 | 88759 | 0.12 | Why? |
| Stomach Neoplasms | 1 | 2018 | 477 | 0.12 | Why? |
| Confidentiality | 1 | 2018 | 581 | 0.12 | Why? |
| HLA Antigens | 1 | 2018 | 830 | 0.12 | Why? |
| Metabolome | 1 | 2017 | 624 | 0.12 | Why? |
| Biological Therapy | 1 | 2017 | 456 | 0.12 | Why? |
| Text Messaging | 1 | 2017 | 389 | 0.12 | Why? |
| Aortic Valve | 1 | 2018 | 664 | 0.12 | Why? |
| Emergency Medical Services | 2 | 2020 | 3557 | 0.12 | Why? |
| Colitis, Ulcerative | 2 | 2018 | 1037 | 0.11 | Why? |
| Counseling | 1 | 2017 | 747 | 0.11 | Why? |
| Retrospective Studies | 19 | 2021 | 105322 | 0.11 | Why? |
| Pancreatic Neoplasms | 1 | 2018 | 609 | 0.11 | Why? |
| Insulin Resistance | 1 | 2017 | 669 | 0.11 | Why? |
| Interleukin-10 | 1 | 2018 | 1409 | 0.11 | Why? |
| Risk Assessment | 6 | 2020 | 25439 | 0.11 | Why? |
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 1014 | 0.11 | Why? |
| Adult | 25 | 2021 | 244371 | 0.10 | Why? |
| Leukemia, Myeloid, Acute | 1 | 2017 | 676 | 0.10 | Why? |
| Killer Cells, Natural | 1 | 2020 | 2093 | 0.10 | Why? |
| Anemia | 1 | 2017 | 789 | 0.10 | Why? |
| Risk Factors | 11 | 2020 | 71621 | 0.10 | Why? |
| Aortic Valve Stenosis | 1 | 2018 | 741 | 0.10 | Why? |
| Pancreatitis | 1 | 2018 | 688 | 0.10 | Why? |
| Patient Acuity | 1 | 2017 | 1755 | 0.10 | Why? |
| Neoplasm Recurrence, Local | 1 | 2017 | 1063 | 0.10 | Why? |
| Switzerland | 4 | 2018 | 2738 | 0.10 | Why? |
| Decision Support Techniques | 1 | 2017 | 903 | 0.10 | Why? |
| Lung | 2 | 2020 | 31049 | 0.10 | Why? |
| Taste Disorders | 1 | 2021 | 1720 | 0.10 | Why? |
| Internal Medicine | 3 | 2021 | 557 | 0.10 | Why? |
| Transcatheter Aortic Valve Replacement | 1 | 2018 | 839 | 0.10 | Why? |
| Electrocardiography | 2 | 2018 | 3957 | 0.10 | Why? |
| Melanoma | 1 | 2020 | 1229 | 0.10 | Why? |
| Metabolic Syndrome | 1 | 2017 | 810 | 0.09 | Why? |
| Risk | 2 | 2018 | 5288 | 0.09 | Why? |
| Coronary Angiography | 1 | 2018 | 2275 | 0.09 | Why? |
| Ventricular Function, Left | 1 | 2017 | 1555 | 0.09 | Why? |
| Prospective Studies | 8 | 2020 | 43301 | 0.09 | Why? |
| Heart Rate | 1 | 2017 | 1527 | 0.09 | Why? |
| Longitudinal Studies | 3 | 2018 | 9893 | 0.09 | Why? |
| Vaccination Coverage | 1 | 2017 | 1249 | 0.09 | Why? |
| Hospital Mortality | 4 | 2020 | 22087 | 0.09 | Why? |
| Graft Rejection | 1 | 2018 | 1766 | 0.09 | Why? |
| Transglutaminases | 2 | 2018 | 77 | 0.08 | Why? |
| Survival Analysis | 2 | 2017 | 7592 | 0.08 | Why? |
| Prevalence | 5 | 2020 | 25773 | 0.08 | Why? |
| Malnutrition | 1 | 2016 | 932 | 0.08 | Why? |
| Methotrexate | 2 | 2017 | 471 | 0.08 | Why? |
| GTP-Binding Proteins | 2 | 2018 | 132 | 0.08 | Why? |
| Vitamin D Deficiency | 1 | 2020 | 1782 | 0.08 | Why? |
| Skin Neoplasms | 1 | 2020 | 1679 | 0.08 | Why? |
| Nutritional Status | 1 | 2017 | 1403 | 0.08 | Why? |
| Diet, Gluten-Free | 2 | 2018 | 185 | 0.08 | Why? |
| Observational Studies as Topic | 1 | 2013 | 1887 | 0.08 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2019 | 3607 | 0.08 | Why? |
| Reference Values | 2 | 2019 | 795 | 0.08 | Why? |
| Blood Pressure | 1 | 2017 | 2198 | 0.08 | Why? |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 1510 | 0.07 | Why? |
| Cardiac Pacing, Artificial | 1 | 2007 | 160 | 0.07 | Why? |
| Enalapril | 1 | 2005 | 54 | 0.07 | Why? |
| Vitamin D | 1 | 2020 | 2904 | 0.07 | Why? |
| Head and Neck Neoplasms | 1 | 2017 | 1568 | 0.07 | Why? |
| Polymyalgia Rheumatica | 1 | 2004 | 64 | 0.07 | Why? |
| Thromboembolism | 1 | 2018 | 2101 | 0.07 | Why? |
| Autoimmune Diseases | 1 | 2018 | 1996 | 0.07 | Why? |
| Information Dissemination | 1 | 2020 | 2986 | 0.07 | Why? |
| Biopsy | 3 | 2018 | 2811 | 0.07 | Why? |
| Survivors | 1 | 2017 | 2619 | 0.07 | Why? |
| Biomarkers | 5 | 2020 | 23361 | 0.07 | Why? |
| Genetic Predisposition to Disease | 1 | 2019 | 4027 | 0.07 | Why? |
| Body Mass Index | 4 | 2018 | 4306 | 0.07 | Why? |
| Immunocompromised Host | 1 | 2020 | 5150 | 0.07 | Why? |
| Nurses | 1 | 2019 | 2285 | 0.07 | Why? |
| Kaplan-Meier Estimate | 3 | 2018 | 4260 | 0.07 | Why? |
| Adrenal Cortex Hormones | 1 | 2020 | 6537 | 0.06 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2020 | 5837 | 0.06 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.06 | Why? |
| Antibodies, Neutralizing | 2 | 2020 | 25288 | 0.06 | Why? |
| Valine | 1 | 2005 | 359 | 0.06 | Why? |
| Arthritis, Rheumatoid | 1 | 2017 | 2043 | 0.06 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.06 | Why? |
| Incidence | 6 | 2021 | 25622 | 0.06 | Why? |
| Olfaction Disorders | 1 | 2021 | 3704 | 0.06 | Why? |
| Echocardiography | 1 | 2017 | 3661 | 0.06 | Why? |
| B-Lymphocytes | 1 | 2018 | 4418 | 0.06 | Why? |
| Physicians | 2 | 2019 | 4214 | 0.06 | Why? |
| Gastrointestinal Diseases | 1 | 2018 | 2580 | 0.06 | Why? |
| Length of Stay | 2 | 2017 | 11042 | 0.06 | Why? |
| Consensus | 1 | 2017 | 6345 | 0.06 | Why? |
| Tetrazoles | 1 | 2005 | 262 | 0.06 | Why? |
| Medical Oncology | 1 | 2018 | 3826 | 0.06 | Why? |
| Prognosis | 7 | 2020 | 32490 | 0.06 | Why? |
| Heart Failure | 2 | 2018 | 6638 | 0.06 | Why? |
| Inflammatory Bowel Diseases | 1 | 2019 | 3209 | 0.06 | Why? |
| Coinfection | 1 | 2021 | 6820 | 0.05 | Why? |
| Multivariate Analysis | 3 | 2018 | 5440 | 0.05 | Why? |
| Cohort Studies | 6 | 2020 | 36005 | 0.05 | Why? |
| Mobile Applications | 1 | 2017 | 3032 | 0.05 | Why? |
| Exercise | 2 | 2019 | 6771 | 0.05 | Why? |
| Mortality | 1 | 2017 | 7132 | 0.05 | Why? |
| Pneumonia | 1 | 2020 | 5652 | 0.05 | Why? |
| Prednisone | 1 | 2004 | 652 | 0.05 | Why? |
| Algorithms | 1 | 2017 | 7346 | 0.05 | Why? |
| Biomedical Research | 1 | 2020 | 5270 | 0.05 | Why? |
| Exercise Test | 2 | 2019 | 911 | 0.05 | Why? |
| Time-to-Treatment | 1 | 2017 | 5883 | 0.05 | Why? |
| Heart Diseases | 1 | 2016 | 3503 | 0.05 | Why? |
| Antibodies, Viral | 3 | 2021 | 51949 | 0.05 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2017 | 5277 | 0.05 | Why? |
| Polymorphism, Restriction Fragment Length | 1 | 2019 | 116 | 0.05 | Why? |
| Pulmonary Embolism | 1 | 2018 | 4775 | 0.05 | Why? |
| Diastole | 1 | 2019 | 168 | 0.05 | Why? |
| Colonic Pouches | 1 | 2018 | 17 | 0.05 | Why? |
| Case-Control Studies | 4 | 2019 | 17671 | 0.05 | Why? |
| Hypertrophy | 1 | 2018 | 86 | 0.05 | Why? |
| Internship and Residency | 1 | 2019 | 4987 | 0.05 | Why? |
| Vena Cava, Superior | 1 | 2018 | 30 | 0.05 | Why? |
| Systole | 1 | 2019 | 252 | 0.05 | Why? |
| Proctocolectomy, Restorative | 1 | 2018 | 51 | 0.04 | Why? |
| Cytokines | 1 | 2020 | 15010 | 0.04 | Why? |
| Age Distribution | 2 | 2018 | 3567 | 0.04 | Why? |
| Kidney Transplantation | 1 | 2018 | 5397 | 0.04 | Why? |
| Acute Kidney Injury | 1 | 2018 | 5762 | 0.04 | Why? |
| Nervous System Diseases | 1 | 2017 | 4092 | 0.04 | Why? |
| Lipids | 1 | 2005 | 1079 | 0.04 | Why? |
| Class I Phosphatidylinositol 3-Kinases | 1 | 2017 | 43 | 0.04 | Why? |
| Antigens, CD19 | 1 | 2018 | 98 | 0.04 | Why? |
| Logistic Models | 3 | 2017 | 9089 | 0.04 | Why? |
| Nutritional Requirements | 1 | 2018 | 115 | 0.04 | Why? |
| Microsatellite Instability | 1 | 2017 | 57 | 0.04 | Why? |
| Chromosome Aberrations | 1 | 2017 | 54 | 0.04 | Why? |
| Organ Size | 1 | 2018 | 384 | 0.04 | Why? |
| Proto-Oncogene Proteins p21(ras) | 1 | 2017 | 100 | 0.04 | Why? |
| Neoplasm Grading | 1 | 2018 | 400 | 0.04 | Why? |
| Young Adult | 8 | 2019 | 93724 | 0.04 | Why? |
| Defibrillators | 1 | 2017 | 144 | 0.04 | Why? |
| Atrophy | 1 | 2017 | 192 | 0.04 | Why? |
| Genotyping Techniques | 1 | 2019 | 360 | 0.04 | Why? |
| Internationality | 2 | 2020 | 3297 | 0.04 | Why? |
| Postoperative Period | 1 | 2019 | 651 | 0.04 | Why? |
| Genotype | 2 | 2019 | 4697 | 0.04 | Why? |
| Autoantibodies | 2 | 2018 | 2094 | 0.04 | Why? |
| Intraoperative Complications | 1 | 2018 | 221 | 0.04 | Why? |
| Ileum | 1 | 2018 | 233 | 0.04 | Why? |
| Anthropometry | 1 | 2017 | 233 | 0.04 | Why? |
| Proto-Oncogene Proteins B-raf | 1 | 2017 | 179 | 0.04 | Why? |
| Receptor, ErbB-2 | 1 | 2017 | 267 | 0.04 | Why? |
| Patients' Rooms | 1 | 2020 | 675 | 0.04 | Why? |
| Abatacept | 1 | 2017 | 192 | 0.04 | Why? |
| Adolescent | 7 | 2018 | 86841 | 0.04 | Why? |
| Catheterization, Peripheral | 1 | 2018 | 249 | 0.04 | Why? |
| Tumor Suppressor Protein p53 | 1 | 2017 | 310 | 0.04 | Why? |
| Blood Safety | 1 | 2020 | 459 | 0.04 | Why? |
| Prealbumin | 1 | 2016 | 203 | 0.04 | Why? |
| Inflammation | 1 | 2017 | 13255 | 0.04 | Why? |
| Endpoint Determination | 1 | 2016 | 344 | 0.04 | Why? |
| Common Variable Immunodeficiency | 1 | 2017 | 195 | 0.03 | Why? |
| Energy Intake | 1 | 2017 | 323 | 0.03 | Why? |
| Walking | 1 | 2019 | 442 | 0.03 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2013 | 10649 | 0.03 | Why? |
| Survival Rate | 2 | 2020 | 9206 | 0.03 | Why? |
| Gene Frequency | 1 | 2019 | 1210 | 0.03 | Why? |
| Cardiovascular Diseases | 1 | 2019 | 11497 | 0.03 | Why? |
| Echocardiography, Transesophageal | 1 | 2018 | 447 | 0.03 | Why? |
| Child | 6 | 2018 | 70012 | 0.03 | Why? |
| Risk Adjustment | 1 | 2018 | 730 | 0.03 | Why? |
| Pandemics | 6 | 2020 | 389249 | 0.03 | Why? |
| Practice Guidelines as Topic | 1 | 2018 | 15421 | 0.03 | Why? |
| Infliximab | 1 | 2018 | 502 | 0.03 | Why? |
| Child, Preschool | 4 | 2018 | 36283 | 0.03 | Why? |
| Age Factors | 3 | 2019 | 21039 | 0.03 | Why? |
| Donor Selection | 1 | 2020 | 804 | 0.03 | Why? |
| Ultrasonography | 2 | 2020 | 4409 | 0.03 | Why? |
| Disease-Free Survival | 1 | 2018 | 1654 | 0.03 | Why? |
| Multicenter Studies as Topic | 1 | 2020 | 2437 | 0.03 | Why? |
| Catheterization, Central Venous | 1 | 2018 | 458 | 0.03 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.03 | Why? |
| Cluster Analysis | 1 | 2021 | 3001 | 0.03 | Why? |
| Neuropsychological Tests | 1 | 2018 | 954 | 0.03 | Why? |
| Lung Compliance | 1 | 2014 | 243 | 0.03 | Why? |
| Glomerular Filtration Rate | 1 | 2018 | 1262 | 0.03 | Why? |
| Multimorbidity | 1 | 2017 | 703 | 0.03 | Why? |
| HIV Infections | 1 | 2018 | 11620 | 0.03 | Why? |
| Drug Therapy, Combination | 3 | 2017 | 7268 | 0.03 | Why? |
| Antibodies | 1 | 2018 | 846 | 0.03 | Why? |
| Secondary Prevention | 1 | 2017 | 762 | 0.03 | Why? |
| Hemoglobins | 1 | 2017 | 958 | 0.03 | Why? |
| Ventricular Dysfunction, Right | 1 | 2019 | 639 | 0.03 | Why? |
| Emergency Responders | 1 | 2017 | 479 | 0.03 | Why? |
| Body Weight | 1 | 2017 | 1074 | 0.03 | Why? |
| History, 21st Century | 1 | 2018 | 1849 | 0.03 | Why? |
| User-Computer Interface | 1 | 2018 | 1068 | 0.03 | Why? |
| Contrast Media | 1 | 2017 | 1011 | 0.03 | Why? |
| Image Interpretation, Computer-Assisted | 1 | 2017 | 665 | 0.03 | Why? |
| Immunohistochemistry | 1 | 2018 | 2275 | 0.03 | Why? |
| Up-Regulation | 1 | 2018 | 2249 | 0.03 | Why? |
| Medical Informatics | 1 | 2018 | 648 | 0.03 | Why? |
| Rituximab | 1 | 2018 | 1096 | 0.03 | Why? |
| False Negative Reactions | 1 | 2017 | 1785 | 0.03 | Why? |
| Sex Distribution | 1 | 2017 | 2083 | 0.03 | Why? |
| Neoplasms | 1 | 2018 | 17251 | 0.02 | Why? |
| Renin-Angiotensin System | 1 | 2005 | 3661 | 0.02 | Why? |
| Tissue Donors | 1 | 2018 | 1679 | 0.02 | Why? |
| Combined Modality Therapy | 1 | 2018 | 3395 | 0.02 | Why? |
| Comorbidity | 3 | 2017 | 34796 | 0.02 | Why? |
| Biomarkers, Tumor | 1 | 2017 | 1314 | 0.02 | Why? |
| Telephone | 1 | 2017 | 1705 | 0.02 | Why? |
| Registries | 2 | 2017 | 12327 | 0.02 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2017 | 2483 | 0.02 | Why? |
| Software | 1 | 2018 | 2501 | 0.02 | Why? |
| Immunoglobulin G | 2 | 2021 | 21571 | 0.02 | Why? |
| Liver | 1 | 2020 | 4007 | 0.02 | Why? |
| Genomics | 1 | 2018 | 3118 | 0.02 | Why? |
| Clinical Decision-Making | 1 | 2019 | 3755 | 0.02 | Why? |
| Hemodynamics | 1 | 2014 | 1562 | 0.02 | Why? |
| World Health Organization | 1 | 2018 | 4213 | 0.02 | Why? |
| Anti-Inflammatory Agents | 1 | 2004 | 6153 | 0.02 | Why? |
| Immunoglobulin A | 1 | 2017 | 3567 | 0.02 | Why? |
| Infant | 2 | 2018 | 30274 | 0.02 | Why? |
| Leucovorin | 1 | 2004 | 70 | 0.02 | Why? |
| Odds Ratio | 1 | 2016 | 5861 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2017 | 6543 | 0.02 | Why? |
| Electronic Health Records | 1 | 2018 | 3492 | 0.02 | Why? |
| Machine Learning | 1 | 2020 | 4395 | 0.02 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2005 | 6166 | 0.02 | Why? |
| Valsartan | 1 | 2005 | 206 | 0.02 | Why? |
| Genetic Variation | 1 | 2018 | 3919 | 0.02 | Why? |
| Hypertension | 1 | 2005 | 8895 | 0.02 | Why? |
| Cardiac Surgical Procedures | 1 | 2016 | 1931 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2018 | 9537 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2019 | 11304 | 0.02 | Why? |
| Primary Health Care | 1 | 2021 | 4839 | 0.02 | Why? |
| Tertiary Care Centers | 1 | 2020 | 8248 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2017 | 7220 | 0.01 | Why? |
| Chronic Disease | 1 | 2017 | 5139 | 0.01 | Why? |
| Liver Diseases | 1 | 2018 | 2698 | 0.01 | Why? |
| Societies, Medical | 1 | 2018 | 6907 | 0.01 | Why? |
| Pacemaker, Artificial | 1 | 2007 | 431 | 0.01 | Why? |
| Radiography, Thoracic | 1 | 2018 | 5486 | 0.01 | Why? |
| Databases, Factual | 1 | 2016 | 6248 | 0.01 | Why? |
| Placebos | 1 | 2004 | 629 | 0.01 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2019 | 3832 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2020 | 7330 | 0.01 | Why? |
| Magnetic Resonance Imaging | 1 | 2017 | 6551 | 0.01 | Why? |
| C-Reactive Protein | 1 | 2016 | 7972 | 0.01 | Why? |
| Ventricular Dysfunction, Left | 1 | 2007 | 993 | 0.01 | Why? |
| Hospitalization | 2 | 2020 | 54280 | 0.01 | Why? |
| Infant, Newborn | 1 | 2018 | 23105 | 0.01 | Why? |
| Models, Statistical | 1 | 2014 | 5312 | 0.01 | Why? |
| Obesity | 1 | 2016 | 7388 | 0.01 | Why? |
| Diabetes Mellitus | 1 | 2018 | 8207 | 0.01 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2017 | 9335 | 0.01 | Why? |
| Double-Blind Method | 1 | 2004 | 5988 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2020 | 53120 | 0.01 | Why? |
| Critical Illness | 1 | 2016 | 17281 | 0.01 | Why? |
| Vaccination | 1 | 2017 | 19050 | 0.01 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2018 | 43792 | 0.01 | Why? |